Detectable Anti-Infliximab Antibodies in Children Treated with Infliximab for Rheumatic Diseases

被引：2
|
作者：
Aeschlimann, Florence A. [1 ]
Hofer, Kevin [1 ]
Schneider, Elvira Cannizzaro [1 ]
Schroeder, Silke [1 ]
Lauener, Roger [2 ]
van der Kleij, Desiree [3 ]
Rispens, Theo [4 ]
Saurenmann, R. K. [5 ]
机构：
[1] Univ Childrens Hosp, Zurich, Switzerland
[2] Ostschweizer Kinderspital St Gallen, St Gallen, Switzerland
[3] Sanquin Diagnost Serv, Amsterdam, Netherlands
[4] Sanquin Res, Amsterdam, Netherlands
[5] Kantonsspital Winterthur, Winterthur, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
10.1002/art.38416
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A5
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [1] Anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 385 - 386
  • [2] ISOTYPE CHARACTERIZATION OF ANTI-INFLIXIMAB ANTIBODIES IN PEDIATRIC PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INFLIXIMAB
    Kosmac, M.
    Toplak, N.
    Simonini, G.
    Cimaz, R.
    Serbec, V. Curin
    Avcin, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 255 - 255
  • [3] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    [J]. PEDIATRIC RESEARCH, 2011, 69 (03) : 243 - 248
  • [4] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab
    Miha Kosmač
    Tadej Avčin
    Nataša Toplak
    Gabriele Simonini
    Rolando Cimaz
    Vladka Čurin Šerbec
    [J]. Pediatric Research, 2011, 69 : 243 - 248
  • [5] Anti-infliximab antibodies in RA patients treated with infliximab.
    Wolbink, GJ
    Lems, WF
    Nurmohamed, MT
    Vis, M
    Voskuyl, AE
    Stapel, S
    de Groot, E
    Tak, PP
    Dijkmans, BA
    Aarden, L
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S187 - S187
  • [6] Therapeutic drug monitoring of infliximab biosimilar and anti-infliximab antibodies in inflammatory diseases
    Elberdin, Laida
    Outeda, Maria
    Mateos, Maria
    Martinez, Cristina
    Salvador, Pilar
    Angeles Porta, Maria
    Isabel Martin, Maria
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 338 - 339
  • [7] Commentary: detection of infliximab levels and anti-infliximab antibodies
    Seow, C. H.
    Panaccione, R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 153 - 154
  • [8] Significance of low level infliximab in the absence of anti-infliximab antibodies
    Bella Ungar
    Adi Anafy
    Henit Yanai
    Yulia Ron
    Miri Yavzori
    Orit Picard
    Ella Fudim
    Ronen Loebstein
    Uri Kopylov
    Yehuda Chowers
    Iris Dotan
    Rami Eliakim
    Shomron Ben-Horin
    [J]. World Journal of Gastroenterology, 2015, (06) : 1907 - 1914
  • [9] Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
    Svenson, M.
    Geborek, P.
    Saxne, T.
    Bendtzen, K.
    [J]. RHEUMATOLOGY, 2007, 46 (12) : 1828 - 1834
  • [10] Anti-infliximab antibodies developed in patients treated for severe hidradenitis suppurativa
    Peeters, M. -A.
    Laffitte, E.
    [J]. EXPERIMENTAL DERMATOLOGY, 2016, 25 : 12 - 12
12345